<DOC>
	<DOCNO>NCT01131273</DOCNO>
	<brief_summary>This study obtain pilot data acceptability 12-week course daily observe suboxone methadone , follow dose taper referral local treatment program 80 opioid dependent patient ( 40 group ) inject subutex buprenorphine preparation 10 day past 30 , impact medication HIV risk subutex opioid use treatment followup week 20. do Uranti Methadone Program , affiliate Addiction Research Center , Union Alternative Georgia Tbilisi .</brief_summary>
	<brief_title>HIV Risk Reduction Subutex Injectors Tbilisi</brief_title>
	<detailed_description />
	<mesh_term>Naloxone</mesh_term>
	<mesh_term>Buprenorphine , Naloxone Drug Combination</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<criteria>current opioid dependence ; inject buprenorphine 10 time last 30 day ; 25 50 year age ; buprenorphine and/or opiate positive urine test ; methadone maintenance last 4 week ; stable address within Tbilisi plan move ; home cellular phone number reach ; able provide name family member know whereabouts ; willingness ability give inform consent . currently dependent alcohol , benzodiazepine CNS depressant ; legan charge impend incarceration ; plan move Tbilisi within next 6 month ; current participation another treatment study ; serious medical problem would impair make hazardous ability participate ; active TB ; currently psychotic/suicidal ; uncontrolled seizure disorder .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>buprenorphine injecting</keyword>
	<keyword>opiate dependence</keyword>
	<keyword>HIV risk</keyword>
	<keyword>treatment outcome</keyword>
	<keyword>opiate dependence buprenorphine injecting</keyword>
</DOC>